000			02116 a2200565 4500
005			20250517231014.0
264		0	_c20190606
008			201906s 0 0 eng d
022			_a1523-1755
024	7		_a10.1016/j.kint.2018.05.002 _2doi
040			_aNLM _beng _cNLM
100	1		_aZhang, Yifan
245	0	0	_aA sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor-dependent pathway after renal injury in mice. _h[electronic resource]
260			_bKidney international _c09 2018
300			_a524-535 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcute Kidney Injury _xdrug therapy
650	0	4	_aAngiogenesis Inhibitors _xpharmacology
650	0	4	_aAnimals
650	0	4	_aBlood Glucose _xmetabolism
650	0	4	_aCapillaries _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aFibrosis
650	0	4	_aGene Knockdown Techniques
650	0	4	_aGlucose Transporter Type 2 _xgenetics
650	0	4	_aHumans
650	0	4	_aKidney Tubules, Proximal _xblood supply
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aReceptors, Vascular Endothelial Growth Factor _xantagonists & inhibitors
650	0	4	_aReperfusion Injury _xcomplications
650	0	4	_aSodium-Glucose Transporter 2 _xmetabolism
650	0	4	_aSodium-Glucose Transporter 2 Inhibitors _xpharmacology
650	0	4	_aSorbitol _xanalogs & derivatives
650	0	4	_aSunitinib _xpharmacology
650	0	4	_aTreatment Outcome
650	0	4	_aVascular Endothelial Growth Factor A _xmetabolism
700	1		_aNakano, Daisuke
700	1		_aGuan, Yu
700	1		_aHitomi, Hirofumi
700	1		_aUemura, Akiyoshi
700	1		_aMasaki, Tsutomu
700	1		_aKobara, Hideki
700	1		_aSugaya, Takeshi
700	1		_aNishiyama, Akira
773	0		_tKidney international _gvol. 94 _gno. 3 _gp. 524-535
856	4	0	_uhttps://doi.org/10.1016/j.kint.2018.05.002 _zAvailable from publisher's website
999			_c28669316 _d28669316